Factor IX stimulants in preclinical and early phase trials for hemophilia B treatment
Sign Up to like & getrecommendations! Published in 2024 at "Expert Opinion on Investigational Drugs"
DOI: 10.1080/13543784.2024.2388565
Abstract: ABSTRACT Introduction Hemophilia B is a X-linked rare inherited bleeding disorder characterized by coagulation factor IX (FIX) deficiency. Therapy for hemophilia B is aimed at replacing the FIX deficiency by means of several plasma-derived or… read more here.
Keywords: treatment; preclinical early; factor stimulants; fix ... See more keywords